De la Cruz JP - Search Results

1

Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.

De la Cruz JP, Pavia J, Garcia-Arnes J, Sanchez de la Cuesta F. De la Cruz JP, et al. Eur J Haematol. 1988 Mar;40(3):232-6. doi: 10.1111/j.1600-0609.1988.tb00829.x. Eur J Haematol. 1988. PMID: 2965654

2

Dipyridamole inhibits platelet aggregation induced by oxygen-derived free radicals.

De la Cruz JP, García PJ, Sánchez de la Cuesta F. De la Cruz JP, et al. Thromb Res. 1992 May 15;66(4):277-85. doi: 10.1016/0049-3848(92)90278-i. Thromb Res. 1992. PMID: 1329255

3

Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.

De La Cruz JP, Cámara S, Frutos MA, Sánchez De La Cuesta F. De La Cruz JP, et al. Eur J Clin Pharmacol. 1992;43(3):307-9. doi: 10.1007/BF02333029. Eur J Clin Pharmacol. 1992. PMID: 1425898

4

The pyrimido-pyrimidine derivative RA-642 protects from brain injury in a combined model of permanent focal ischemia and global ischemia reperfusion.

De La Cruz JP, Villalobos MA, Carrasco T, Smith-Agreda JM, Sánchez de la Cuesta F. De La Cruz JP, et al. Brain Res. 1992 Dec 4;597(2):250-6. doi: 10.1016/0006-8993(92)91481-s. Brain Res. 1992. PMID: 1472997

5

Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes.

de la Cruz JP, Carrasco T, Ortega G, Sanchez de la Cuesta F. de la Cruz JP, et al. Lipids. 1992 Mar;27(3):192-4. doi: 10.1007/BF02536177. Lipids. 1992. PMID: 1522764

6

Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase.

de la Cruz JP, Mata JM, Sanchez de la Cuesta F. de la Cruz JP, et al. Gen Pharmacol. 1992 Mar;23(2):297-300. doi: 10.1016/0306-3623(92)90027-h. Gen Pharmacol. 1992. PMID: 1639242

7

Dipyridamole and RA-642 inhibit the production of superoxide anion and free radical damage to rat lens.

De la Cruz JP, Sintas A, Moreno A, Garcia-Campos J, Sanchez de la Cuesta F. De la Cruz JP, et al. Pharmacol Toxicol. 1991 Sep;69(3):201-4. doi: 10.1111/j.1600-0773.1991.tb01297.x. Pharmacol Toxicol. 1991. PMID: 1665562

8

Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642.

de la Cruz JP, Moron D, Sanchez de la Cuesta F. de la Cruz JP, et al. Thromb Res. 1991 Aug 15;63(4):463-8. doi: 10.1016/0049-3848(91)90233-m. Thromb Res. 1991. PMID: 1754999 No abstract available.

9

Effects of dipyridamole on the short-term evolution of glomerulonephritis.

Camara S, de la Cruz JP, Frutos MA, Sanchez P, Lopez de Novales E, Sanchez E, Sanchez de la Cuesta F. Camara S, et al. Among authors: de la cruz jp. Nephron. 1991;58(1):13-6. doi: 10.1159/000186370. Nephron. 1991. PMID: 1857478 Clinical Trial.

10

The pyrimido-pyrimidine derivative RA-642: a potent inhibitor of ferrous-induced lipid peroxidation in cell membranes.

Bellido I, de la Cruz JP, Sánchez de la Cuesta F. Bellido I, et al. Among authors: de la cruz jp. Methods Find Exp Clin Pharmacol. 1991 Jul-Aug;13(6):371-5. Methods Find Exp Clin Pharmacol. 1991. PMID: 1881198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters